World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
97
Citations
38718
World Ranking
813
National Ranking
457

Medicine

D-Index
97
Citations
38913
World Ranking
9195
National Ranking
4742

William A. Blattner publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where William A. Blattner sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 422 publications — 83rd percentile

83% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

William A. Blattner D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where William A. Blattner sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 97 D-Index — 84th percentile

84% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

William A. Blattner is affiliated with the University of Maryland, Baltimore in the United States. Their research is primarily situated within the fields of Medicine and Immunology and Microbiology, with particular focus on subfields such as Virology, Infectious Diseases, Epidemiology, Public Health, Environmental and Occupational Health, and Neurology.

The scientist's work addresses several topics related to HIV/AIDS, including HIV Research and Treatment, HIV/AIDS drug development and treatment, Neuroinflammation and Neurodegeneration Mechanisms, HIV-related health complications and treatments, HIV/AIDS Research and Interventions, Cervical Cancer and HPV Research, and HIV/AIDS oral health manifestations.

Frequent publication venues for their scholarly output include:

  • UNC Libraries
  • JAIDS Journal of Acquired Immune Deficiency Syndromes
  • AIDS Research and Therapy
  • Scientific Reports
  • Virology Journal

Some notable recent papers authored or co-authored by William A. Blattner include:

  • "Immune status, and not HIV infection or exposure, drives the development of the oral microbiota" (2020, Scientific Reports)
  • "Elevated Plasma Levels of sCD14 and MCP-1 Are Associated With HIV Associated Neurocognitive Disorders Among Antiretroviral-Naive Individuals in Nigeria" (2020, JAIDS Journal of Acquired Immune Deficiency Syndromes)
  • "Epidemiologic and viral predictors of antiretroviral drug resistance among persons living with HIV in a large treatment program in Nigeria" (2020, AIDS Research and Therapy)
  • "Predictors of first-line antiretroviral therapy failure among adults and adolescents living with HIV/AIDS in a large prevention and treatment program in Nigeria" (2020, AIDS Research and Therapy)
  • "High-Risk Human Papillomavirus Persistence and Anal Microbiota Among Nigerian Men Who Have Sex With Men Living With or At Risk for HIV" (2020, JCO Global Oncology)

William A. Blattner collaborates frequently with several researchers, including Manhattan Charurat, Nicaise Ndembi, Trevor A. Crowell, Jibreel Jumare, and Peter Alabi.

Best Publications

  • Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection

    Brandon F. Keele;Elena E. Giorgi;Elena E. Giorgi;Jesus F. Salazar-Gonzalez;Julie M. Decker

  • A cancer family syndrome in twenty-four kindreds.

    Frederick P. Li;Joseph F. Fraumeni;John J. Mulvihill;William A. Blattner

  • Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome.

    Shiv Srivastava;Zhiqiang Zou;Kathleen Pirollo;William Blattner

  • Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission.

    Ellen R. Cooper;Manhattan Charurat;Lynne Mofenson;I. Celine Hanson

  • Influence of combinations of human major histocompatibility complex genes on the course of HIV–1 infection

    Richard A. Kaslow;Mary Carrington;R. Apple;L. Park

  • Initial B-Cell Responses to Transmitted Human Immunodeficiency Virus Type 1: Virion-Binding Immunoglobulin M (IgM) and IgG Antibodies Followed by Plasma Anti-gp41 Antibodies with Ineffective Control of Initial Viremia

    Georgia D. Tomaras;Nicole L. Yates;Pinghuang Liu;Li Qin

  • The human type-C retrovirus, HTLV, in blacks from the Caribbean region, and relationship to adult T-cell leukemia/lymphoma

    W A Blattner;V S Kalyanaraman;M Robert-Guroff;T A Lister

  • A Prospective Study of Human Immunodeficiency Virus Type 1 Infection and the Development of AIDS in Subjects with Hemophilia

    James J. Goedert;Craig M. Kessler;Louis M. Aledort;Robert J. Biggar

  • ADULT T-CELL LYMPHOMA-LEUKAEMIA IN BLACKS FROM THE WEST INDIES

    D Catovsky;M Rose;A.W.G Goolden;J.M White

  • Infective dermatitis of Jamaican children: a marker for HTLV-I infection.

    W. Blattner;L. LaGrenade;B. Hanchard;V. Fletcher

  • Modelling the risk of adult T-cell leukemia/lymphoma in persons infected with human T-lymphotropic virus type I.

    E. L. Murphy;B. Hanchard;J. P. Figueroa;W. N. Gibbs

  • Clinical course of retrovirus-associated adult T-cell lymphoma in the United States.

    Paul A. Bunn;Geraldine P. Schechter;Elaine Jaffe;Douglas Blayney

  • Cancer Incidence in Nigeria: A Report from Population-based Cancer Registries

    Elima Jedy-Agba;Maria Paula Curado;Olufemi Ogunbiyi;Emmanuel Oga

  • Screening Test for HTLV-III (AIDS Agent) Antibodies: Specificity, Sensitivity, and Applications

    Stanley H. Weiss;James J. Goedert;M. G. Sarngadharan;Anne J. Bodner

  • Serum HIV-1 RNA levels and time to development of AIDS in the Multicenter Hemophilia Cohort Study

    Thomas R. O'Brien;William A. Blattner;David Waters;M. Elaine Eyster

  • Prevalence of antibodies to HTLV-I, -II, and -III in intravenous drug abusers from an AIDS endemic region.

    Marjorie Robert-Guroff;Stanley H. Weiss;Jose A. Giron;Andrea M. Jennings

  • DETERMINANTS OF RETROVIRUS (HTLV-III) ANTIBODY AND IMMUNODEFICIENCY CONDITIONS IN HOMOSEXUAL MEN

    James J. Goedert;Robert J. Biggar;Deborah M. Winn;Mark H. Greene

  • Non‐Hodgkin's lymphoma among people with AIDS: Incidence, presentation and public health burden

    Timothy R. Coté;Robert J. Biggar;Philip S. Rosenberg;Susan S. Devesa

  • Effect of T4 count and cofactors on the incidence of AIDS in homosexual men infected with human immunodeficiency virus.

    James J. Goedert;Robert J. Biggar;Mads Melbye;Dean L. Mann

  • Sexual transmission of human T-lymphotropic virus type I (HTLV-I).

    E L Murphy;J P Figueroa;W N Gibbs;A Brathwaite

Frequent Co-Authors

Robert C. Gallo
Robert C. Gallo University of South Florida
James J. Goedert
James J. Goedert National Institutes of Health
Robert J. Biggar
Robert J. Biggar National Institutes of Health
Dean L. Mann
Dean L. Mann University of Maryland, Baltimore
Elaine S. Jaffe
Elaine S. Jaffe National Institutes of Health
Edward L. Murphy
Edward L. Murphy University of California, San Francisco
Marjorie Robert-Guroff
Marjorie Robert-Guroff National Institutes of Health
Clement Adebamowo
Clement Adebamowo University of Maryland, Baltimore
Linda Morris Brown
Linda Morris Brown RTI International
Joseph F. Fraumeni
Joseph F. Fraumeni National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare fields through online degrees can open diverse career pathways. Many students choose to complement their immunology knowledge with clinical practice by enrolling in nursing programs designed for accelerated entry, such as 12-month accelerated nursing programs online for non nurses, which cater to individuals switching careers into healthcare.

Finding convenient study options is crucial for busy learners. Many prospective students search for accelerated nursing programs near me, ensuring they can access support and clinical placements locally while still benefiting from flexible online coursework.

For those starting their nursing careers, Licensed Practical Nurse (LPN) programs serve as a foundational step. Investigating which lpn programs are easiest to get into helps applicants identify pathways with manageable admissions criteria and quicker entry times, facilitating a faster transition into healthcare roles related to immunology.

Additionally, nurses aiming to advance their qualifications should consider which nurse practitioner program is easiest to join. These programs often allow for specialization in areas connected to immunology, such as infectious disease or immunotherapy, helping professionals elevate their impact in patient care and research.

Best Scientists Citing William A. Blattner

Trending Scientists

Recently Published Articles